INVIVO THERAPEUTICS HOLDINGS CORP. Annual Depreciation in USD from 2011 to 2022

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Invivo Therapeutics Holdings Corp. quarterly/annual Depreciation history and growth rate from 2011 to 2022.
Invivo Therapeutics Holdings Corp. Depreciation for the quarter ending September 30, 2023 was $4K, a 71.4% decline year-over-year.
Invivo Therapeutics Holdings Corp. Depreciation for the twelve months ending September 30, 2023 was $53K, a 8.16% increase year-over-year.
Invivo Therapeutics Holdings Corp. annual Depreciation for 2022 was $60K, a 71.4% increase from 2021.
Invivo Therapeutics Holdings Corp. annual Depreciation for 2021 was $35K, a 20.7% increase from 2020.
Invivo Therapeutics Holdings Corp. annual Depreciation for 2020 was $29K, a 25.6% decline from 2019.

Depreciation, Trailing 12 Months (USD)

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$60K	+$25K	+71.4%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-01
2021	$35K	+$6K	+20.7%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-01
2020	$29K	-$10K	-25.6%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-07
2019	$39K	-$35K	-47.3%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-01
2018	$74K	-$303K	-80.4%	Jan 1, 2018	Dec 31, 2018	10-K	2020-02-20
2017	$377K	-$159K	-29.7%	Jan 1, 2017	Dec 31, 2017	10-K	2019-04-01
2016	$536K	-$136K	-20.2%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-12
2015	$672K	-$63K	-8.57%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-12
2014	$735K	+$734K	+101560%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-10
2013	$723	-$366K	-99.8%	Jan 1, 2013	Dec 31, 2013	10-K	2016-03-04
2012	$367K	+$235K	+178%	Jan 1, 2012	Dec 31, 2012	10-K	2015-03-11
2011	$132K			Jan 1, 2011	Dec 31, 2011	10-K	2014-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.